Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

Henry C. Fung, FRCP, MD, Sunita Nathan, MD, Neel B. Shah, MD, John J. Maciejewski, MD, PhD, Elizabeth Shima Rich, MD, PhD, Jennifer Tornatta, MS, ANP, Nancy Licciardi, Parameswaran Venugopal, MD, Reem Karmali, MD, Stephanie A. Gregory, MD

Blood (2011) 118 (21): 4205.

https://doi.org/10.1182/blood.V118.21.4205.4205

Published: 2011

Journal Articles

A Novel Approach to the Treatment of Early Stage Hodgkin Lymphoma with a Mitoxantrone-Based Regimen Followed by Involved Field Radiotherapy: A 12 Year Follow up

Arlene Dawravoo, MD, Neel B. Shah, MD, Teresa O'Brien, Stephanie A. Gregory, MD, Parmeswaran Venugopal, MD

Blood (2010) 116 (21): 4901.

https://doi.org/10.1182/blood.V116.21.4901.4901

Published: 2010

Journal Articles

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

Neel B. Shah, MD, Melissa L. Larson, MD, Nitin Goyal, Ann M. Thomas, Jamile M. Shammo, MD, John J. Maciejewski, MD, PhD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2008) 112 (11): 4004.

https://doi.org/10.1182/blood.V112.11.4004.4004

Published: 2008

Journal Articles

The Role of FDG-PET in Hodgkin Lymphoma S/P Autologous Hematopoietic Cell Transplant (HCT) as a Predictor of Outcome.

Neel B. Shah, MD, Mohamed Farhat, M.D., Arti Lakhani, M.D., Daniel Mcfarland, D.O., Parameswaran Venugopal, M.D., Stephanie A Gregory, M.D., Jamile Shammo, M.D., John Maciejewski, M.D., Hande Tuncer, M.D., Henry C Fung, M.D.

Blood (2008) 112 (11): 2178.

https://doi.org/10.1182/blood.V112.11.2178.2178

Published: 2008

Journal Articles

Immune Ablation Using Cyclophosphamide without Stem Cell Rescue for Intractable Multiple Sclerosis and Its Variants

Julie R Nangia, Jamile M. Shammo, MD, Shilpa D Tilwalli, Roumen Balabanov, Dusan Stefoski, George Katsamakis, Michael Ko, Neel B Shah, Mohamed I Farhat, Alla Gimelfarb, Kathryn Shell, Katherine Bueschel, Stephanie A. Gregory

Blood (2008) 112 (11): 4903.

https://doi.org/10.1182/blood.V112.11.4903.4903

Published: 2008

NARROW

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

A Novel Approach to the Treatment of Early Stage Hodgkin Lymphoma with a Mitoxantrone-Based Regimen Followed by Involved Field Radiotherapy: A 12 Year Follow up

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

The Role of FDG-PET in Hodgkin Lymphoma S/P Autologous Hematopoietic Cell Transplant (HCT) as a Predictor of Outcome.

Immune Ablation Using Cyclophosphamide without Stem Cell Rescue for Intractable Multiple Sclerosis and Its Variants

Email alerts

ASH Publications

American Society of Hematology

A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma — Limited Utility of Post-Transplant Surveillance Computerized Axial Tomography (CAT scan) and/or PET Scan,

A Novel Approach to the Treatment of Early Stage Hodgkin Lymphoma with a Mitoxantrone-Based Regimen Followed by Involved Field Radiotherapy: A 12 Year Follow up

Effective Remission Induction for AML Using Two Days of Chemotherapy: Older Patients Tolerate and Respond Equally Well

The Role of FDG-PET in Hodgkin Lymphoma S/P Autologous Hematopoietic Cell Transplant (HCT) as a Predictor of Outcome.

Immune Ablation Using Cyclophosphamide without Stem Cell Rescue for Intractable Multiple Sclerosis and Its Variants

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only